期刊文献+

临床药师参与1例AECOPD合并肝肾功能损害的药学监护

Pharmaceutical Care of Clinical Pharmacists Participating in a Case of AECOPD Combined With Liver and Kidney Function Damage
下载PDF
导出
摘要 目的:探讨临床药师在药物治疗中的作用。方法:临床药师参与1例AECOPD合并肝肾功能损害患者的药学监护,针对患者住院过程中出现的肝肾功能损害,帮助医生调整药物治疗方案。结果:临床药师对药物治疗方案的干预与建议得到医师采纳,取得较好的疗效。结论:临床药师运用临床思维参与药物治疗分析,协助临床优化治疗方案,保证了药物治疗的安全性与有效性。 Objective: To investigate the role of clinical pharmacist in drug therapy.Methods: Clinical pharmacists participated in a case of AECOPD combined with liver and kidney function damage with pharmaceutical care, clinical pharmacists help doctors adjust drug treatment plan.Results: The drug treatment plan and the proposed method of clinical pharmacists have been adopted by the doctors.Conclusions: Clinical pharmacists use clinical thinking to participate in drug treatment analysis, to assist in the optimization of clinical treatment plan, to ensure the safety and effectiveness of drug treatment.
出处 《药品评价》 CAS 2016年第2期50-53,59,共5页 Drug Evaluation
关键词 临床药师 AECOPD 药学监护 肝肾功损害 Clinical Pharmacist AECOPD Pharmaceutical Care Liver and Kidney Function Damage
  • 相关文献

参考文献7

二级参考文献14

  • 1钟惠菊,韩秀云,方育川,谭少珍,高东初.PGE_1治疗糖尿病周围神经病变的初步观察[J].中华内分泌代谢杂志,1995,11(2):115-116. 被引量:64
  • 2Turbiner J,Amin M B,Humphrey P A,刘飞飞(摘译),张仁亚(审校).囊性肾瘤、肾脏混合性上皮和间质肿瘤34例临床病理分析[J].临床与实验病理学杂志,2007,23(3):341-341. 被引量:29
  • 3LEE KS,KIM SR,PARK HS,et al.Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression[J].J Allergy Clin lmmunol,2004,114(5):1093-1099. 被引量:1
  • 4KARAMAN O,SUNNELI L,UZUNER N,et al.Evaluation of montelukast in 8 to 14 year old children with mild persistent asthma and compared with inhaled corticosteroids[J].Allergol Immunopathol (Madr),2004,32 (1):21-27. 被引量:1
  • 5CIPRANDI G,TOSCA MA,MILANESE M,et al.Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis:histamine and leukotriene antagonism[J].Allerg Immunol (Paris),2004,36(2):67 -70,72. 被引量:1
  • 6KITCHEN CJ,WANG AQ,MUSSON DG,et al.A semi-automated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/fluorescence detection[J].J Pharm Biomed Anal,2003,31 (4):647 -654. 被引量:1
  • 7AL-RAWITHI S,AL-GAZLAN S,AL-AHMADI W,et al.Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma[J].J Chromatogr B Biomed Sci Appl,2001,754 (2):527 -531. 被引量:1
  • 8MIGOYA E,KEARNS GL,HARTFORD A,et al.Pharmacokineticsof montelukast in asthmatic patients 6 to 24 months old[J].J Clin Pharmacol,2004,44 (5):487-494. 被引量:1
  • 9KNORR B,LARSON P,NGUYEN HH,et al.Montelukast dose selection in 6-to 14-year-olds:comparison of single-dose pharmacokinetics in children and adults[J].J Clin Pharmacol,1999,39(8):786-793. 被引量:1
  • 10WALSKY RL,GAMAN EA,OBACH RS.Examination of 209 drugs for inhibition of cytochrome P450 2C8[J].J Clin Pharmacol,2005,45(1):68 -78. 被引量:1

共引文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部